Detailed slide-by-slide text content extracted from this presentation.
Slide 01
Biomedical Engineering
- Engineering Meets Medicine
- From prosthetic limbs carved in ancient Egypt to CRISPR gene editing, the story of humanity's quest to engineer better health.
- A comprehensive exploration in 32 slides
- 1 / 32
Slide 02
What Is Biomedical Engineering?
- Biomedical engineering applies principles of engineering and the natural sciences to medicine and biology. It spans the design of diagnostic devices, therapeutic equipment, pharmaceutical manufacturing processes, and regenerative therapies.
- "Biomedical engineering is the application of engineering principles and design concepts to medicine and biology for healthcare purposes."
- -- National Institutes of Health (NIH) definition
- $595BGlobal medical device market (2024)
- 240,000+Biomedical engineers worldwide
- 7.6%Annual job growth rate (U.S.)
- 2 / 32
Slide 03
Ancient Origins
- The impulse to engineer solutions for the human body is as old as civilization itself. Archaeological evidence reveals surprisingly sophisticated early medical devices.
- Cairo Toe (c. 950 BCE)
- Discovered near the ancient city of Thebes in Egypt, this wooden and leather prosthetic toe is considered the oldest known functional prosthesis. Testing on volunteers showed it genuinely improved walking in sandals.
- Sushruta Samhita (c. 600 BCE)
- Indian physician Sushruta described over 120 surgical instruments including forceps, scalpels, and catheters. He also pioneered reconstructive surgery techniques such as the forehead rhinoplasty flap.
- Roman Dental Implants (c. 200 CE)
- Iron dental implants found in Roman-era skulls in France show early attempts at tooth replacement. Some showed evidence of bone integration -- a concept not formally described until the 1950s.
- Aztec Obsidian Blades
- Pre-Columbian surgeons used obsidian blades that could achieve an edge just 3 nanometers wide -- far sharper than modern steel scalpels. Some surgeons today still prefer obsidian for delicate procedures.
- 3 / 32
Slide 04
Timeline of Key Milestones
- 1628
- William Harvey publishes De Motu Cordis, describing blood circulation -- the first quantitative model of a biological system.
- 1816
- Rene Laennec invents the stethoscope after rolling paper into a tube to listen to a patient's heartbeat, creating the first non-invasive diagnostic device.
- 1895
- Wilhelm Rontgen discovers X-rays. Within a year, X-ray machines appear in hospitals across Europe and America.
- 1938
- Willem Kolff begins work on the first dialysis machine in Nazi-occupied Netherlands, completing it in 1943 from sausage casings and orange-juice cans.
- 1958
- Ake Senning and Rune Elmqvist implant the first internal cardiac pacemaker in Arne Larsson in Stockholm. It failed after 3 hours; the second lasted 2 days. Larsson outlived both engineers, dying in 2001 at age 86.
- 4 / 32
Slide 05
Timeline of Key Milestones (continued)
- 1967
- Christiaan Barnard performs the first human heart transplant in Cape Town, South Africa. Patient Louis Washkansky survived 18 days.
- 1971
- Godfrey Hounsfield develops the first CT scanner at EMI Laboratories, funded partly by profits from Beatles record sales.
- 1982
- Barney Clark receives the Jarvik-7 artificial heart at the University of Utah. He survived 112 days, tethered to a 400-pound compressor.
- 2004
- FDA approves the first implantable brain-computer interface (BrainGate) for clinical trials. Patient Matthew Nagle moves a computer cursor with his thoughts.
- 2020
- BioNTech and Moderna develop mRNA COVID-19 vaccines in under 11 months -- a bioengineering triumph built on 30 years of mRNA research by Katalin Kariko.
- 5 / 32
Slide 06
Core Disciplines of BME
- Biomedical engineering is not a single field but a constellation of overlapping specializations, each blending engineering methods with biological understanding.
- Biomechanics
- Applies mechanics to biological systems: joint loading, gait analysis, injury mechanisms, prosthetics design.
- Biomaterials
- Develops materials compatible with living tissue: titanium implants, biodegradable sutures, hydrogels, ceramic bone grafts.
- Medical Imaging
- Creates technologies to see inside the body: MRI, CT, PET, ultrasound, optical coherence tomography.
- Tissue Engineering
- Grows functional tissues and organs using scaffolds, cells, and biochemical signals. Lab-grown bladders were implanted in 2006.
- Neural Engineering
- Interfaces electronics with the nervous system: cochlear implants, deep brain stimulators, brain-computer interfaces.
- Clinical Engineering
- Manages medical equipment in hospitals: maintenance, safety testing, procurement, staff training on 10,000+ device types.
- 6 / 32
Slide 07
Biomaterials: Engineering Compatibility
- "A biomaterial is a substance that has been engineered to interact with biological systems for a medical purpose -- whether therapeutic or diagnostic."
- -- David F. Williams, European Society for Biomaterials, 1987
- Generations of Biomaterials
- 1st Generation (1950s-70s): Bioinert materials -- stainless steel, PMMA, silicone. Goal: do no harm. Used in early hip replacements.
- 2nd Generation (1980s-2000s): Bioactive materials -- hydroxyapatite, bioactive glass. Bond to living tissue. Larry Hench invented Bioglass in 1969.
- 3rd Generation (2000s-present): Bioresorbable and instructive materials that stimulate specific cellular responses, then dissolve. Includes biodegradable stents.
- 4th Generation (emerging): Smart biomaterials that respond to stimuli -- pH, temperature, light -- and release drugs on demand.
- Key Materials
- Titanium (Ti-6Al-4V)
- The gold standard for orthopedic implants. Used in 80% of hip replacements. Osseointegrates with bone. First used by Per-Ingvar Branemark in 1965 for dental implants.
- PEEK (Polyether Ether Ketone)
- Radiolucent polymer replacing metal in spinal fusion cages. Elastic modulus closer to bone, reducing stress shielding. Market exceeded $800M by 2023.
- 7 / 32
Slide 08
Medical Imaging Technologies
- Medical imaging transformed medicine from an art of inference to a science of visualization. Each modality exploits different physical phenomena.
- X-ray & CT
- X-rays exploit differential absorption of ionizing radiation. CT scanning (1971) reconstructs 3D volumes from 2D projections. Modern CT scanners rotate 4 times per second, producing images in under 1 second. The mathematics behind CT -- the Radon transform -- was described in 1917, decades before practical use.
- MRI
- Uses strong magnetic fields (1.5-7 Tesla) to align hydrogen atoms, then measures radio-frequency signals as they relax. No ionizing radiation. Raymond Damadian performed the first full-body MRI in 1977 -- the scan took 4 hours 45 minutes. Today: under 30 minutes. A 2023 Hyperfine Swoop portable MRI costs $50,000 vs. $3M for conventional systems.
- Ultrasound
- Uses sound waves at 2-18 MHz. Real-time, portable, no radiation. Ian Donald pioneered obstetric ultrasound in Glasgow in 1958. Modern 3D/4D ultrasound provides detailed fetal imaging. Point-of-care devices like the Butterfly iQ use a single semiconductor chip instead of piezoelectric crystals.
- PET/SPECT
- Detects gamma rays from injected radioactive tracers. PET uses FDG (fluorodeoxyglucose) to image metabolic activity -- critical for cancer staging. Combined PET/CT scanners (introduced 2001) provide both anatomical and functional data simultaneously.
- 8 / 32
Slide 09
Prosthetics: From Wood to Bionics
- The evolution of prosthetics mirrors the trajectory of biomedical engineering itself -- from passive replacements to active, intelligent devices.
- c. 950 BCE
- The Cairo Toe -- wood and leather prosthetic found in an Egyptian tomb near Luxor.
- 1508
- Gotz von Berlichingen, a German knight, commissions an iron hand with articulating fingers operated by spring mechanisms after losing his right hand to cannon fire.
- 1858
- Dubois Parvaz introduces the "American arm" with body-powered cable controls -- the basic design used for over a century.
- 1993
- MIT's Hugh Herr (himself a double amputee) begins developing powered ankle-foot prostheses that use computer-controlled actuators to replicate natural gait.
- 2015
- DARPA's Revolutionizing Prosthetics program produces the LUKE arm (named after Luke Skywalker). The modular prosthesis features 26 joints, can crack eggs, and is controlled by foot movements or EMG signals.
- 9 / 32
Slide 10
The Bionic Future of Prosthetics
- "There are no disabled people -- only disabled technology."
- -- Hugh Herr, MIT Media Lab, 2014 TED Talk
- Osseointegration
- Titanium implants fused directly to bone eliminate the socket, improving comfort and control. Pioneered by Rickard Branemark (son of dental implant inventor) at Sahlgrenska University Hospital, Sweden. Over 500 patients worldwide by 2023. Sensory feedback transmitted through bone.
- Targeted Muscle Reinnervation
- Developed by Todd Kuiken at the Rehabilitation Institute of Chicago. Nerves originally controlling the amputated limb are redirected to chest muscles, which then generate EMG signals to control a robotic arm intuitively.
- 3D-Printed Prosthetics
- Organizations like e-NABLE produce open-source 3D-printed prosthetic hands for children costing as little as $50 -- compared to $5,000-$50,000 for conventional devices. Over 10,000 delivered by 2023.
- Neural-Integrated Limbs
- The Swedish e-Opra implant system (2023) enables a patient to feel pressure and temperature through an above-elbow prosthesis via electrodes connected to remaining arm nerves -- the first fully neuromusculoskeletal prosthesis used daily.
- 10 / 32
Slide 11
Artificial Organs
- With over 100,000 people on the U.S. organ transplant waiting list, and 17 dying daily while waiting, artificial organs represent one of biomedical engineering's most urgent frontiers.
- Artificial Heart
- The AbioCor total artificial heart (2001) was the first fully self-contained replacement. Modern devices like the SynCardia weigh 160 grams and pump 9 liters/minute. The Carmat Aesa, approved in the EU in 2020, uses bioprosthetic membranes and embedded sensors to auto-regulate cardiac output.
- Dialysis Machines
- Hemodialysis sustains 3.7 million patients worldwide. Willem Kolff's 1943 rotating drum has evolved into portable devices. The Wearable Artificial Kidney (WAK), under FDA review, weighs under 5 kg and runs continuously.
- Artificial Pancreas
- Closed-loop insulin delivery systems combine continuous glucose monitors with insulin pumps and control algorithms. The Medtronic 780G system (2020) adjusts insulin every 5 minutes, reducing hypoglycemia by 50% in Type 1 diabetes patients.
- Cochlear Implants
- The most successful neural prosthesis: over 1 million implanted worldwide since 1978. Converts sound into electrical signals sent to the auditory nerve via 22 electrodes. Graeme Clark's prototype was inspired by threading grass into a seashell on a beach in Melbourne.
- 11 / 32
Slide 12
Tissue Engineering & Regenerative Medicine
- "One day, engineering will eliminate the organ shortage. We will build tissue and organs as readily as we build bridges."
- -- Robert Langer, MIT Institute Professor and tissue engineering pioneer
- The Triad of Tissue Engineering
- All tissue engineering approaches combine three elements:
- Cells: Stem cells, primary cells, or iPSCs (induced pluripotent stem cells, discovered by Shinya Yamanaka in 2006, Nobel Prize 2012)
- Scaffolds: 3D structures guiding cell growth -- biodegradable polymers (PLGA), decellularized organs, hydrogels, electrospun nanofibers
- Signals: Growth factors, mechanical forces, electrical stimulation that direct cell differentiation
- Landmark Achievements
- 1997: The "Vacanti mouse" -- a human-ear-shaped cartilage scaffold grown on a mouse's back by Charles Vacanti. Became the most iconic (and misunderstood) image in biomedical engineering.
- 2006: Anthony Atala at Wake Forest implants lab-grown bladders in 7 patients, the first engineered organs in humans. All functioning years later.
- 2019: Tel Aviv University researchers 3D-print a miniature heart using patient-derived cells -- the first 3D-printed organ with cells, blood vessels, and chambers.
- 12 / 32
Slide 13
3D Bioprinting
- Bioprinting deposits living cells layer by layer to create functional tissue constructs. The technology has progressed from simple cell-laden hydrogels to vascularized tissue with embedded sensor networks.
- How It Works
- Bioink: Cells suspended in hydrogel (alginate, gelatin, collagen, hyaluronic acid)
- Extrusion printing: Most common; pushes bioink through nozzles at 10-100 micron resolution
- Inkjet printing: Deposits picoliter droplets at high speed; thermal or piezoelectric actuation
- Laser-assisted: Uses laser pulses to propel cell-laden droplets onto substrate; highest resolution
- Stereolithography: UV light cures photosensitive bioinks; complex geometries possible
- Current Capabilities
- Skin grafts bioprinted directly onto burn wounds (Wake Forest, 2019)
- Ear cartilage implanted in human patient (3DBio Therapeutics, 2022)
- Liver tissue for drug testing (Organovo, commercial since 2014)
- Corneal tissue printed in 6 minutes (Newcastle University, 2018)
- Bone scaffolds with integrated growth factor gradients
- Market size: $1.9 billion (2023), projected $8.3 billion by 2030
- 13 / 32
Slide 14
Brain-Computer Interfaces
- BCIs translate neural activity into commands for external devices, restoring communication and movement to people with paralysis.
- Non-Invasive BCIs
- EEG-Based
- Hans Berger recorded the first human EEG in 1924. Modern EEG-BCIs use machine learning to decode intentions from scalp recordings. Limited by low spatial resolution (~1 cm) and signal attenuation through the skull. Used commercially for neurofeedback and basic game control.
- fNIRS
- Functional near-infrared spectroscopy measures blood oxygenation changes through the scalp. Portable and inexpensive. Kernel's Flow headset (2021) packs 52 channels into a bicycle-helmet form factor.
- Invasive BCIs
- Utah Array (BrainGate)
- A 4mm x 4mm grid of 96 silicon microelectrodes implanted in motor cortex. In 2012, patient Cathy Hutchinson used it to control a robotic arm and drink coffee -- 15 years after her stroke left her paralyzed.
- Neuralink N1
- 1,024 electrodes on 64 ultra-thin threads, implanted by a surgical robot. First human implant in January 2024 (patient Noland Arbaugh). Achieved cursor control and gameplay within weeks. Wireless data transmission at 1 Mbps.
- 14 / 32
Slide 15
Genetic Engineering in Medicine
- The ability to read, write, and edit DNA has transformed biomedical engineering from repairing bodies to reprogramming them.
- 1973
- Stanley Cohen and Herbert Boyer create the first recombinant DNA organism, launching the biotechnology industry.
- 1982
- Humulin (recombinant human insulin by Genentech/Eli Lilly) becomes the first genetically engineered drug approved by the FDA. Replaced insulin extracted from pig and cow pancreases.
- 2003
- The Human Genome Project completes sequencing all 3.2 billion base pairs of human DNA. Cost: $2.7 billion over 13 years. By 2023, a full genome sequence costs under $200 and takes hours.
- 2012
- Jennifer Doudna and Emmanuelle Charpentier publish the CRISPR-Cas9 gene editing system. Nobel Prize in Chemistry, 2020.
- 2023
- Casgevy (CRISPR-based) becomes the first gene-editing therapy approved by regulators (UK MHRA), treating sickle cell disease and beta-thalassemia by editing patients' own blood stem cells.
- 15 / 32
Slide 16
Drug Delivery Systems
- "The right drug, at the right dose, at the right time, to the right target."
- -- The mantra of targeted drug delivery
- Nanoparticles
- Liposomes (50-200 nm) encapsulate drugs and release them at specific sites. Doxil (1995) was the first FDA-approved nanodrug -- liposomal doxorubicin for cancer. The COVID-19 mRNA vaccines use lipid nanoparticles (~80 nm) to deliver mRNA to cells.
- Implantable Devices
- Microchip-based implants release precise drug doses on command. MicroCHIPS (MIT spinoff) demonstrated a wirelessly controlled implant that released osteoporosis drug doses over 1 year in clinical trials (2012).
- Microneedle Patches
- Arrays of 100-1500 micron needles painlessly penetrate the skin's outer layer. Can deliver vaccines without refrigeration -- critical for developing nations. Mark Prausnitz at Georgia Tech has pioneered dissolving microneedle patches for flu vaccination.
- Antibody-Drug Conjugates
- Monoclonal antibodies act as guided missiles, delivering cytotoxic drugs specifically to cancer cells. Kadcyla (2013) targets HER2-positive breast cancer. Over 14 ADCs approved by FDA as of 2024, with 100+ in clinical trials.
- 16 / 32
Slide 17
Organ-on-a-Chip Technology
- Organ-on-a-chip devices are microfluidic cell culture systems that replicate the functions of human organs on a thumbnail-sized chip. They promise to revolutionize drug testing and reduce animal experimentation.
- How It Works
- Tiny channels (50-500 microns) lined with living human cells replicate organ-level physiology. Mechanical forces (stretching, flow) mimic breathing, peristalsis, and blood flow. Multiple organ chips can be connected -- creating a "human-on-a-chip."
- By the Numbers
- 90% of drugs that pass animal testing fail in human trials
- Average drug development cost: $2.6 billion
- Average development time: 12-15 years
- Organ chips can reduce preclinical testing time by 40-60%
- Pioneering Work
- Wyss Institute Lung-on-a-Chip (2010)
- Donald Ingber's team at Harvard created the first organ-on-a-chip -- a breathing lung chip with an air-liquid interface that contracts rhythmically. Correctly predicted human drug toxicity responses that animal tests missed.
- FDA Modernization Act 2.0 (2022)
- U.S. law no longer requires animal testing for drug approval. Organ chips, organoids, and computer models now accepted as alternatives. A paradigm shift for the $180 billion pharmaceutical industry.
- 17 / 32
Slide 18
Surgical Robotics
- Robotic surgery combines precision engineering with computer vision to extend the capabilities of human surgeons beyond the limits of hand-eye coordination.
- Da Vinci Surgical System
- Developed by Intuitive Surgical (founded 1995), the da Vinci system has performed over 12 million procedures since its FDA approval in 2000. Four robotic arms with 7 degrees of freedom, 10x magnified 3D vision, and tremor filtration. Wristed instruments bend and rotate beyond human capability. Over 9,000 systems installed worldwide. Cost: $1.5-2.5 million per unit.
- Next-Generation Systems
- Medtronic Hugo: Modular arms, open platform, lower cost target
- CMR Surgical Versius: Small, portable arms that can be configured for different procedures
- STAR (Smart Tissue Autonomous Robot): Johns Hopkins system that sutured pig intestines autonomously in 2022, outperforming human surgeons
- Monarch Platform: Endoscopy robot by J&J navigating the lung's bronchial tree for biopsy -- reaching lesions previously inaccessible
- "Robotic surgery is not about replacing surgeons -- it's about giving them superhuman precision."
- -- Catherine Mohr, VP of Strategy, Intuitive Surgical
- 18 / 32
Slide 19
Wearable Medical Devices
- Wearable sensors are shifting healthcare from episodic clinic visits to continuous, real-time monitoring -- a fundamental transformation of medicine.
- $72BGlobal wearable medical device market (2024)
- 1.1BWearable devices shipped (2023)
- 30%Reduction in ER visits with continuous monitoring
- Continuous Glucose Monitors (CGM)
- A filament sensor under the skin measures interstitial glucose every 1-5 minutes. Dexcom G7 and Abbott FreeStyle Libre 3 transmit wirelessly to smartphones. Over 6 million users worldwide. Originally for diabetics, now used by non-diabetics for metabolic health optimization.
- Smart Watches as Medical Devices
- Apple Watch Series 4 (2018) introduced FDA-cleared ECG monitoring. Has detected atrial fibrillation in users unaware of their condition. The Apple Heart Study (2019) enrolled 419,297 participants -- the largest heart rhythm study ever. Apple Watch can now detect sleep apnea, wrist temperature, and blood oxygen.
- 19 / 32
Slide 20
AI in Biomedical Engineering
- Artificial intelligence is accelerating every domain of biomedical engineering, from drug discovery to diagnostics.
- Medical Imaging AI
- Deep learning algorithms now match or exceed radiologists in specific tasks. Google's DeepMind detected over 50 eye diseases from OCT scans with 94% accuracy (2018). FDA has approved over 700 AI-enabled medical devices as of 2024, most in radiology.
- Drug Discovery
- AlphaFold (DeepMind, 2020) predicted the 3D structure of virtually all 200 million known proteins -- a problem that had stymied biologists for 50 years. Insilico Medicine used AI to identify a novel drug candidate for idiopathic pulmonary fibrosis in 18 months (vs. typical 4-5 years), entering Phase II trials in 2023.
- Pathology
- Digital pathology AI can analyze a tissue slide in seconds vs. 10-30 minutes for a human pathologist. Paige AI received the first FDA approval for AI-based cancer diagnosis in prostate pathology (2021). Detects cancer in biopsy slides with 99.6% sensitivity.
- Clinical Decision Support
- Sepsis prediction algorithms (e.g., Epic's model deployed in 100+ hospitals) alert clinicians 4-6 hours before clinical onset. Early intervention reduces sepsis mortality by 18-24%. However, some models have shown racial and socioeconomic biases requiring careful validation.
- 20 / 32
Slide 21
Rehabilitation Engineering
- Rehabilitation engineering develops technology to restore function after injury or disability, combining biomechanics, neuroscience, and control theory.
- Exoskeletons
- ReWalk (2014)
- First FDA-approved powered exoskeleton for personal use. Enables paraplegic users to stand, walk, and climb stairs. Battery-powered hip and knee motors. Weight: 23 kg. Used by over 500 patients worldwide. Cost: ~$85,000.
- EksoNR
- Used in 350+ rehabilitation centers. Variable assist mode lets therapists precisely control how much the exoskeleton helps, promoting neural plasticity. Stroke patients using robotic exoskeletons show 2x improvement in walking speed compared to conventional therapy.
- Functional Electrical Stimulation (FES)
- Electrical currents activate paralyzed muscles to produce functional movement. FES cycling allows spinal cord injury patients to pedal a stationary bike using their own legs.
- Epidural Stimulation Breakthrough
- In 2018, researchers at the University of Louisville enabled three paraplegic patients to walk with assistance using epidural spinal cord stimulators combined with intensive training. The stimulators, placed over the lumbar spine, reactivate dormant neural circuits. By 2023, over 40 patients had regained some voluntary movement.
- 21 / 32
Slide 22
Biomechanics: Engineering the Human Machine
- "The human body is the most complex machine in the known universe. A femur can withstand forces of 1,700 pounds. The Achilles tendon handles 3-4x body weight with every step."
- -- Y.C. Fung, father of modern biomechanics
- Computational Biomechanics
- Finite element analysis (FEA) models the stress distribution in bones, joints, and implants. A modern hip implant design undergoes millions of simulated loading cycles before physical prototyping. Patient-specific models from CT scans now guide surgical planning -- custom cutting guides for knee replacements reduce operating time by 20 minutes.
- Sports Biomechanics
- Motion capture systems (Vicon, OptiTrack) with 200+ fps cameras and force plates measure athletic performance. Eliud Kipchoge's sub-2-hour marathon was aided by biomechanical analysis optimizing his stride length (1.90m), cadence (185 spm), and the carbon-fiber plate in his Nike Vaporfly shoes.
- Injury Biomechanics
- Crash test dummies (Hybrid III, since 1976) contain 130+ sensors measuring forces, accelerations, and deflections. Data has driven safety improvements saving an estimated 300,000+ lives. The THOR dummy (2020s) includes a biofidelic spine and pelvis for improved side-impact assessment.
- Cardiovascular Biomechanics
- Computational fluid dynamics models blood flow through arteries, predicting where plaques will form. The heart pumps ~7,500 liters of blood daily through 100,000 km of vessels. Wall shear stress below 0.4 Pa correlates with atherosclerotic plaque development.
- 22 / 32
Slide 23
Regulatory Landscape
- Every medical device must navigate a complex regulatory pathway before reaching patients. The framework balances innovation speed against patient safety.
- FDA Classification (United States)
- Class I (low risk): Bandages, stethoscopes, tongue depressors. 510(k) exempt. ~47% of devices.
- Class II (moderate risk): X-ray machines, powered wheelchairs, pregnancy tests. Requires 510(k) clearance (demonstrate substantial equivalence). ~43% of devices.
- Class III (high risk): Pacemakers, artificial hearts, cochlear implants. Requires Premarket Approval (PMA) with clinical trial data. ~10% of devices.
- Average 510(k) review: 6 months. Average PMA review: 1-3 years.
- Global Regulatory Bodies
- EU MDR (2021): European Medical Device Regulation replaced the MDD. Far stricter: reclassified many devices upward. Notified body capacity bottleneck caused delays in 2022-23.
- Japan PMDA: Unique "Sakigake" fast-track program for breakthrough devices. Approved regenerative medicine products under a conditional framework.
- China NMPA: Streamlined pathway since 2018 reforms. China's medical device market is the world's second-largest at $95 billion (2023).
- 23 / 32
Slide 24
Ethics in Biomedical Engineering
- Biomedical engineering raises profound ethical questions at the intersection of technology, medicine, and human identity.
- Enhancement vs. Therapy
- Where does restoring function end and enhancing it begin? Oscar Pistorius's carbon-fiber running blades sparked debate about whether prosthetics could provide competitive advantage. CRISPR could theoretically enhance intelligence or physical traits in embryos -- the germline editing debate ignited when He Jiankui created gene-edited babies in China (2018), receiving a 3-year prison sentence.
- Access and Equity
- A cochlear implant costs $30,000-$50,000. Gene therapy Zolgensma for spinal muscular atrophy: $2.1 million per dose. Who gets access? The global medical device industry is concentrated: the U.S. and EU account for 70% of the $595B market while serving 15% of the world's population.
- Data Privacy
- Wearable devices generate terabytes of intimate health data. Who owns it? Continuous glucose monitors track eating habits. Brain-computer interfaces could reveal thoughts. The EU's GDPR classifies health data as "special category" requiring explicit consent. But enforcement is inconsistent.
- Algorithmic Bias
- Pulse oximeters overestimate blood oxygen in patients with darker skin -- a known flaw since the 1990s that contributed to worse COVID-19 outcomes. AI diagnostic tools trained primarily on data from European populations may underperform for other groups. The FDA now requires diversity in clinical trial data.
- 24 / 32
Slide 25
Pioneers of Biomedical Engineering
- Willem Kolff (1911-2009)
- Dutch physician who invented the dialysis machine (1943), the membrane oxygenator (1955), and co-developed the first artificial heart (1957). Worked in secret during the Nazi occupation. Emigrated to the U.S. in 1950. Called the "father of artificial organs."
- Robert Langer (b. 1948)
- MIT Institute Professor with 1,400+ patents -- the most of any living engineer. Pioneered controlled drug release using biodegradable polymers. Co-founded Moderna. His students and postdocs have founded over 400 companies. Member of all three U.S. National Academies.
- Yuan-Cheng "Bert" Fung (1919-2019)
- Father of modern biomechanics. At UC San Diego, he established the constitutive equations for biological tissues (Fung's Law for soft tissues). His 1965 textbook Foundations of Solid Mechanics remains essential reading. Lived to 100.
- Gordana Vunjak-Novakovic (b. 1953)
- Serbian-American pioneer in tissue engineering at Columbia University. Developed bioreactor systems that grow functional heart tissue, bone, and cartilage. Her lab's engineered cardiac patches have been used in human trials. National Medal of Technology recipient (2023).
- 25 / 32
Slide 26
BME Education and Careers
- Top Programs (U.S. News 2024)
- 1. Johns Hopkins University -- The first BME department in the U.S. (1962). Founded by Murray Sachs.
- 2. Georgia Tech / Emory -- Joint program, largest BME department in the U.S. with 65+ faculty.
- 3. MIT -- Emphasis on convergence of engineering and life sciences. Home to Robert Langer and many startups.
- 4. Duke University -- Strong in biomaterials, imaging, and tissue engineering.
- 5. Stanford University -- Biodesign program places students in hospitals to identify unmet clinical needs.
- Career Paths
- Industry (60%): Medical device companies (Medtronic, J&J, Boston Scientific, Stryker), pharma, biotech startups. Median salary: $100,730 (U.S., 2023).
- Academia/Research (20%): University labs, NIH, national labs. PhD typically required. Postdoc common. Tenure-track positions highly competitive.
- Clinical (10%): Hospital clinical engineering, regulatory affairs, medical science liaisons.
- Entrepreneurship (10%): BME graduates found startups at twice the rate of other engineering disciplines. MIT's BME alumni have co-founded companies worth over $50 billion combined.
- 26 / 32
Slide 27
BME for Global Health
- "The vast majority of medical devices are designed for the richest 10% of the world. We need frugal innovation."
- -- George Whitesides, Harvard University
- Paper-Based Diagnostics
- George Whitesides's group developed microfluidic paper-based analytical devices (microPADs) that cost pennies. A drop of blood wicks through patterned wax channels on paper, producing color changes that indicate disease. Can detect HIV, malaria, liver disease, and glucose without electricity.
- mHealth in Africa
- Peek Vision's smartphone-based eye exam app has screened over 2 million people in Kenya, Botswana, and Pakistan. A $10 smartphone adapter replaces a $25,000 slit-lamp microscope. 90% of vision impairment in developing countries is preventable or treatable.
- Low-Cost Ventilators
- The MIT E-Vent project (2020) designed an open-source emergency ventilator using a $300 bag-valve-mask with automated compression. During COVID-19, the design was replicated in 90+ countries. Similar frugal ventilators from India (AgVa, $2,000) served thousands.
- Thermoelectric Vaccine Storage
- Arktek by Global Good (a Gates Foundation initiative) keeps vaccines cold for 35+ days without electricity using ice and vacuum insulation. Deployed across Senegal, Ethiopia, and the DRC. Critical for maintaining the cold chain in regions where 50% of vaccines are wasted due to temperature excursions.
- 27 / 32
Slide 28
Emerging Frontiers
- The next decades of biomedical engineering will be defined by convergence -- of biology with computing, of nanoscale with macro-scale, of diagnosis with therapy.
- Xenotransplantation
- Genetically modified pig organs for human transplant. In January 2022, David Bennett received a pig heart at the University of Maryland -- surviving 2 months. By 2024, pig kidney transplants in brain-dead patients showed function for 60+ days. Key gene edits knock out pig viruses and sugar molecules that trigger rejection.
- Optogenetics
- Light-sensitive proteins (channelrhodopsins) are genetically inserted into neurons, allowing precise neural activation with light pulses. Karl Deisseroth (Stanford) demonstrated control of specific behaviors in mice. GenSight Biologics used optogenetics to partially restore vision in a blind patient (2021).
- Theranostics
- Combining therapy and diagnostics in one agent. Radioligand therapy (e.g., Pluvicto for prostate cancer) uses the same molecule to image a tumor (diagnostic) and deliver radiation to it (therapy). The theranostics market is projected to reach $180 billion by 2030.
- Synthetic Biology
- Engineered bacteria that detect and treat disease inside the body. Synlogic has developed E. coli strains that consume toxic metabolites in patients with phenylketonuria (PKU). CAR-T cell therapy (Kymriah, 2017) engineers a patient's own T-cells to attack cancer.
- Digital Twins
- Patient-specific computational models that simulate organ function. Siemens Healthineers' digital heart twin predicts arrhythmia outcomes. The EU's Virtual Physiological Human initiative aims to model the entire human body computationally by 2030.
- Ingestible Sensors
- Proteus Digital Health developed a sand-grain-sized sensor (approved 2017) swallowed with pills that confirms medication adherence. MIT's ingestible robots (2016) unfold in the stomach to patch wounds or deliver drugs. Atmo Biosciences has gas-sensing capsules mapping the microbiome in real time.
- 28 / 32
Slide 29
Grand Challenges
- The National Academy of Engineering and biomedical research communities have identified critical challenges for the field.
- Scaling Tissue Engineering
- We can grow patches of tissue, but vascularizing thick organs remains unsolved. Without blood supply, cells more than 200 microns from a surface die. SWIFT bioprinting (Harvard, 2019) creates perfusable vascular channels, but scaling to full organs requires networks with vessels as small as 5 microns -- the diameter of a capillary.
- Chronic Implant Biocompatibility
- The body's foreign body response encapsulates implants in fibrous tissue, degrading sensor accuracy and electrode signals. Brain implants lose 50-70% of recording neurons within 6 months. New approaches include zwitterionic coatings, shape-matching soft electronics, and immunomodulatory drug-eluting surfaces.
- Cybersecurity of Medical Devices
- In 2017, the FDA recalled 465,000 St. Jude pacemakers due to hacking vulnerabilities. Hospital ransomware attacks increased 300% during COVID-19. As devices become networked, attack surfaces expand. The FDA now requires cybersecurity plans in all new device submissions.
- Reproducibility Crisis
- An estimated 50-70% of preclinical biomedical studies cannot be reproduced. This costs $28 billion annually in the U.S. alone. Cell line misidentification, batch-to-batch variability in biomaterials, and publication bias all contribute. Initiatives like the ARRIVE guidelines aim to improve reporting standards.
- 29 / 32
Slide 30
The Medical Device Industry
- $595BGlobal market (2024)
- ~34,000Medtech companies in the U.S.
- $50B+Annual R&D spending
- Top Companies (2024 Revenue)
- Medtronic: $32.4B -- pacemakers, insulin pumps, spinal implants
- Johnson & Johnson MedTech: $30.4B -- orthopedics, surgical robots
- Abbott: $22.3B -- diagnostics, CGMs (FreeStyle Libre)
- Siemens Healthineers: $22.1B -- imaging, lab diagnostics
- Boston Scientific: $14.2B -- cardiac, endoscopy, neuromodulation
- Stryker: $20.5B -- orthopedic implants, surgical navigation
- Startup Ecosystem
- Medtech startups raised $18.5 billion in venture funding in 2023 (down from $26B in 2021). Key areas: AI diagnostics, surgical robotics, digital therapeutics, and point-of-care testing.
- Notable exits: Grail (cancer screening) acquired by Illumina for $7.1B (2021). Heartflow (CT-based cardiac imaging) IPO'd at $2.4B valuation.
- Average time from concept to FDA clearance: 3-7 years for Class II, 7-12 years for Class III.
- 30 / 32
Slide 31
The Future of Biomedical Engineering
- "In the next 20 years, we will see the convergence of artificial intelligence, synthetic biology, and nanotechnology create medical capabilities that seem like science fiction today."
- -- Eric Topol, Deep Medicine, 2019
- Predictions for 2030-2040
- Whole-organ bioprinting reaches clinical trials by 2030
- AI-designed drugs enter the market routinely; drug development timelines halved
- Wireless, dust-sized neural interfaces (neural dust) enable non-surgical BCIs
- Personalized medicine becomes standard: treatments tailored to individual genomes, microbiomes, and digital twin simulations
- Closed-loop drug delivery systems autonomously manage chronic diseases
- Pig organ transplantation becomes routine for kidneys and hearts
- Convergence Themes
- Bio + Digital: Continuous monitoring feeds AI models that predict disease weeks before symptoms
- Bio + Nano: Nanorobots patrol the bloodstream, clearing arterial plaques and detecting cancer cells
- Bio + Quantum: Quantum computing accelerates protein folding simulations and drug interaction modeling
- Bio + Space: Tissue engineering in microgravity enables organ growth impossible on Earth; NASA ISS experiments ongoing
- 31 / 32
Slide 32
The Engineer's Oath to Life
- From Kolff's dialysis machine made of sausage casings to CRISPR therapies rewriting the code of life, biomedical engineering has always been driven by a single imperative: to reduce suffering and extend the boundaries of human possibility.
- "The human body breaks. It is the engineer's job to fix what nature cannot."
- -- Willem Kolff
- Biomedical Engineering -- A Presentation
- 32 / 32
